Showing posts with label hysterectomy. Show all posts
Showing posts with label hysterectomy. Show all posts

Friday, February 8, 2013

New surgery helps prevent ovarian cancer


New surgery helps prevent ovarian cancer


KGW Staff
Posted on February 7, 2013 at 3:59 PM

PORTLAND, Oregon -- Doctors at a Portland hospital have joined some others across the nation and Canada in following a new recommendation aimed at preventing one of the deadliest forms of cancer in women.
“This is something so simple that could save a lot of lives,” said Dr. Nathalie Johnson, the Medical Director of the Legacy Cancer Institute. Johnson is recommending women who have tubal ligations or hysterectomies have their fallopian tubes removed.
"It’s because researchers have found the tubes attract cancer cells which can eventually encase the ovary," she said. "You could actually find a normal ovary wrapped in cancer and realize the cancer was starting in the fallopian tube and not the ovary."
The recommendation is supported by research on thousands of women. Legacy researcher Dr. Ann Smith-Shedev has studied the connection for more than a decade.
“We think this could cut the most common type of ovarian cancer by up to 70 percent,” Shedev said.
The Legacy Cancer Institute is the first program in Oregon to make the recommendation that women consider the fallopian tube removal if they’re scheduling a tubal ligation or hysterectomy.
“We’d like to raise awareness and hopefully it can become the standard here in Oregon and across the country,” said Johnson.


** I had several massive experimental surgeries in the early 1970's for lymphedema at Good Samaritan Hospital, which is now Legacy. My questions are, "is this really the answer?  Have you also warned your patients about the possibility of leg or abdominal lymphedema from such a surgery?"  Your peers in the 1960's at the Oregon Health Sciences University wrote a very interesting article about abdominal/leg lymphedema from an abdominal surgery. Pat**

Sunday, January 6, 2013

Paulinda Schimmel Babbini: Raising ovarian cancer awareness


Paulinda Schimmel Babbini: Raising ovarian cancer awareness




Often, when someone is coping with an extraordinary loss, the feelings can be all-encompassing. When Paulinda Schimmel Babbini’s daughter, Robin, died of ovarian cancer at the age of 20, instead of letting the tragic death immobilize her, Babbini made it her mission that no one else should go through what she had.

Babbini is the founder and president of The Ovarian Cancer Circle, a foundation she started in 2010 in memory of her daughter. In 2004, Robin, at age 16, was homecoming queen and co-captain of the cheerleading squad at Pacific Hills High School. That same year she also started complaining of cramps. Doctors brushed it off, saying it was her menstrual cycle. The symptoms persisted, however, and a year later she was diagnosed with stage-three ovarian cancer. Robin underwent a hysterectomy and chemotherapy treatments, and was able to enter into her first year of college at University of California, Santa Barbara. Six months later, the cancer recurred; she lost her tumultuous battle in 2006. 

Since its founding, the nonprofit Ovarian Cancer Circle, which includes 12 members, has raised more than $35,000 to fight ovarian cancer. 

“My focus for starting The Circle is to give ovarian cancer a higher public profile; to support research, educate, heighten awareness to the signs and symptoms of this cancer; and to raise funds for an early-detection test, which does not yet exist,” Babbini said. “So many lives are saved by mammograms, Pap smears and PSA tests [for prostate cancer]. But ovarian cancer is a stealth cancer, almost hidden, with few, and random, symptoms.” They are abdominal pressure, bloating, nausea, indigestion, feeling full but eating less, urinary frequency and constipation, she said. “Knowledge is critically important. I encourage women to pay attention to their bodies, know the symptoms and go to the gynecologist.”

Her group holds fundraisers twice a year and participates in numerous health fairs. They’ve hosted events at Hamburger Mary’s, featuring drag-queen bingo, along with a stand-up show at The Comedy Store in West Hollywood that showcased Sinbad as the headliner. On Feb. 21 at 11:30 a.m., Ovarian Cancer Circle is putting together a luncheon at Ruth’s Chris Steak House in Woodland Hills. The group will donate 100 percent of the proceeds to ovarian cancer research. On the Web site, theovariancancercircle.org, donations can be made by purchasing bracelets, scarves and necklaces in teal, the color designated to represent ovarian cancer, at Robin’s Store. 

Dalia Hayon, a friend, said she admires Paulinda for her strength and giving demeanor. “As a mother and grandmother, I would not have been able to bear the pain. It takes a special person and a mensch to be able to put aside her suffering, [to] be such an advocate for her girl and make sure other people are aware of it and know more about what to expect. She wasn’t expecting to get, but to give. She is a very giving person.”

For her part, Babbini said everything she does is in memory of her daughter. “Robin is my inspiration, motivation and strength. Her spirit inspires me to stay focused and, with steadfast determination, make a difference.”

Saturday, December 29, 2012

Nail toxicity associated with Paclitaxel treatment for ovarian cancer.


Nail toxicity associated with Paclitaxel treatment for ovarian cancer.


Jan 2103

Source

Park Nicollet Institute, St. Louis Park, MN.

Abstract


A 57-year-old woman named C. B. began experiencing abdominal pain and bloating. She presented to her primary physician with these symptoms, and her physician palpated an adenexal mass on pelvic examination. That prompted a computed tomography (CT) scan of the abdomen and pelvis, which demonstrated omental thickening as well as a mildly enlarged left ovary. After initial consultation with a gynecologic oncologist, C. B. was taken to surgery and a total abdominal hysterectomy bilateral salpingo-oophorectomy omentectomy partial bowel resection, and pelvic and periaortic lymph node dissection were performed. C. B. was diagnosed with stage IV ovarian cancer involving the omentum, pelvic lymph nodes, and bowel wall and was subsequently referred for postoperative chemotherapy.

Saturday, November 3, 2012

In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.


In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk.


Oct 2012

Source

School of Population Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, M431, 35 Stirling Highway, Crawley, WA, 6009, Australia. Electronic address: louise.stewart@uwa.edu.au.

Abstract


OBJECTIVES:

To examine the risk of invasive epithelial ovarian cancer in a cohort of women seeking treatment for infertility.

METHODS:

Using whole-population linked hospital and registry data, we conducted a cohort study of 21,646 women commencing hospital investigation and treatment for infertility in Western Australia in the years 1982-2002. We examined the effects of IVF treatment, endometriosis and parity on risk of ovarian cancer and explored potential confounding by tubal ligation, hysterectomy and unilateral oophorectomy/salpingo-oophorectomy (USO).

RESULTS:

Parous women undergoing IVF had no observable increase in the rate of ovarian cancer (hazard ratio [HR] 1.01; 95% confidence interval [CI] 0.35 to 2.90); the HR in women who had IVF and remained nulliparous was 1.76 (95% CI 0.74 to 4.16). Women diagnosed with endometriosis who remained nulliparous had a three-fold increase in the rate of ovarian cancer(HR 3.11; 95% CI 1.13 to 8.57); the HR in parous women was 1.52 (95% CI 0.34 to 6.75). In separate analyses, women who had a USO without hysterectomy had a four-fold increase in the rate of ovarian cancer (HR 4.23; 95% CI 1.30 to 13.77). Hysterectomy with or without USO appeared protective.

CONCLUSIONS:

There is no evidence of an increased risk of ovarian cancer following IVF in women who give birth. There is some uncertainty regarding the effect of IVF in women who remain nulliparous. Parous women diagnosed with endometriosis may have a slightly increased risk of ovarian cancer, nulliparous women have a marked increase in risk.